Hormone therapy and risk of venous thromboembolism among postmenopausal women

Abstract : Venous thromboembolism, either deep vein thrombosis or pulmonary embolism, is a serious side-effect of postmenopausal hormone therapy. Current use of oral estrogens increases the risk of venous thromboembolism, especially during the first year of treatment, but past users of hormone therapy have a similar risk as never-users. Among women at high risk for venous thromboembolism (for example, thrombogenic mutations, obesity), oral estrogens use further enhances the thrombotic risk. Recent studies have shown that transdermal estrogens might be safe with respect to thrombotic risk. The difference in thrombotic risk between oral and transdermal estrogens may be partially explained by changes in hemostasis. Few data are currently available regarding the impact of progestogens on venous thromboembolism risk, but norpregnane derivatives might be thrombogenic. Individual assessment of the benefit-risk ratio is needed before initiating treatment and oral estrogens should be avoided among women at high risk for venous thromboembolism.
Type de document :
Article dans une revue
Climacteric, Taylor & Francis, 2009, 12 (s1), pp.76-80. 〈10.1080/13697130903006837〉
Liste complète des métadonnées

Littérature citée [13 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01142910
Contributeur : Pascale Sztajnbok <>
Soumis le : jeudi 16 avril 2015 - 11:38:47
Dernière modification le : mercredi 29 novembre 2017 - 09:36:52
Document(s) archivé(s) le : lundi 14 septembre 2015 - 09:41:30

Fichier

Canonico_Climacteric_2009.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Marianne Canonico, Pierre-Yves Scarabin. Hormone therapy and risk of venous thromboembolism among postmenopausal women. Climacteric, Taylor & Francis, 2009, 12 (s1), pp.76-80. 〈10.1080/13697130903006837〉. 〈inserm-01142910〉

Partager

Métriques

Consultations de la notice

194

Téléchargements de fichiers

78